CURLF logo

CURLF Curaleaf Holdings, Inc.

Other OTC · Drug Manufacturers - Specialty & Generic · Healthcare

$9.47
-0.20 (-2.08%)

Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czec…

Market Cap: $2.50Bwww.curaleaf.com

Price (90d)

$9.87
$8.28$9.51$10.74$11.97
May 4Aug 11

Signal Score (90d)

60
6091122153
Aug 11Aug 12

Quote

Day Range
$9.12 – $9.75
52-Week Range
$5.40 – $15.15
Volume
$55.9K
Market Cap
$2.50B
50-Day Avg
$9.65
200-Day Avg
$8.52
Prev Close
$9.67
Open
$9.70

Valuation & Ratios

P/E Ratio
-8.13
EPS
$-0.93
P/B Ratio
2.54
P/S Ratio
1.49
Debt/Equity
1.37
Current Ratio
1.52
Dividend Yield
+0.0%
Gross Margin
+38.6%

Returns & Efficiency

Return on Equity
-31.1%
Return on Assets
-8.3%
FCF Yield
+3.9%
EV/EBITDA
17.10

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$1.29B$-235.12M$-0.93
2024$1.28B$-226.73M$-0.87
2023$1.37B$-286.35M$-1.20
2022$1.22B$-355.43M$-1.59
2021$1.19B$-204.13M$-0.48

Social Signal Score

57
5d
58
6 mentions
+5.1%
30d
57
6 mentions
+5.9%
60d
57
6 mentions
+2.7%
90d
57
6 mentions
-3.5%
news: 6

Earnings

Wed, Nov 4(in 3 months)

Consensus estimate $-0.16 per share

7of 7 quarters beat consensus

Typical surprise +37.5% (median, so one quarter with a near-zero estimate can't distort it)

  • Wed, Aug 5$0.05 vs $-0.17beat
  • Tue, May 5$0.27 vs $-0.24beat
  • Thu, Feb 26$-0.05 vs $-0.08beat
  • Wed, Nov 5$-0.06 vs $-0.07beat
  • Wed, Aug 6$-0.06 vs $-0.07beat
  • Thu, May 8$-0.07 vs $-0.07beat

Estimates and results for CURLF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

CURLFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (6)

  • Newsfool.com·3d ago·Neutral

    Is Acquiring Aurora Cannabis a Good Move for Curaleaf? Curaleaf has announced a hostile bid for Aurora Cannabis. Aurora has a strong international presence, but it's had challenges with staying out of the red.

    View source ↗
  • Newsfool.com·3d ago·Positive

    Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here's What This Means for Investors. Aurora criticized key aspects of the bid, but will consider it. The major appeal of Aurora is its strong medical marijuana business.

    View source ↗
  • Newsproactiveinvestors.com·3d ago·Neutral

    Curaleaf launches hostile bid for Aurora Cannabis Curaleaf Hldgs Inc. (OTCQX:CURLF) has launched a hostile bid to acquire Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB), offering Aurora shareholders a combination of Curaleaf shares and cash that values the proposal at US$4 per Aurora share, as it seeks to combine the companies' international cannabis operations. Under the proposed transaction, Aurora shareholders would receive 0.3463 Curaleaf shares plus US$0.75 in cash for each Aurora share.

    View source ↗
  • Newsinvezz.com·4d ago·Neutral

    Tilray Brands stock rises as Curaleaf plots hostile takeover for Aurora Tilray Brands stock rose by nearly 4% as investors rotated to companies in the cannabis industry after a report said that Curaleaf was planning a hostile bid for Aurora Cannabis. TLRY rose to an intraday high of 4.70, up by 25% from its lowest level this year.

    View source ↗
  • Newswsj.com·4d ago·Neutral

    Curaleaf Plans Hostile Bid for Rival Aurora Cannabis Curaleaf plans to launch a $272 million unsolicited takeover bid to acquire Canadian cannabis company Aurora after its board repeatedly refused to negotiate an acquisition deal.

    View source ↗
  • Newsprnewswire.com·4d ago·Positive

    Curaleaf Announces Intention to Launch Take-Over Bid for Aurora Cannabis to Solidify its Position as the Global Cannabis Industry Leader Proposed Offer reflects a 45% premium to Aurora's 30-day VWAP and a 110% premium to Aurora's 30-day VWAP excluding balance sheet cash  Provides Aurora shareholders with the opportunity to become owners of the premier global cannabis platform and participate in the significant long-term upside of the combined company Combines Aurora's EU-GMP cultivation and manu

    View source ↗